Lipoprotein(a)の血小板凝集能, 粘着能におよぼす影響

Increased plasma level of lipoprotein (a) (Lp(a)) is associated with atherosclerosis and vascular disease. Though it is well known that there is a strong interaction between Lp(a) and resting platelets, there are no clinical studies on the relationship between Lp(a) and platelet adhesion and aggrega...

Full description

Saved in:
Bibliographic Details
Published in動脈硬化 Vol. 24; no. 12; pp. 825 - 829
Main Authors 瀧川, 修, 小熊, 利明, 布施川, 雄一, 安藤, 泰彦, 半田, 俊之介, 多田, 博巳, 玉地, 寛光, 川田, 勉, 椎名, 豊, 後藤, 俊哉
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本動脈硬化学会 1997
Japan Atherosclerosis Society
Subjects
Online AccessGet full text
ISSN0386-2682
2185-8284
DOI10.5551/jat1973.24.12_825

Cover

Abstract Increased plasma level of lipoprotein (a) (Lp(a)) is associated with atherosclerosis and vascular disease. Though it is well known that there is a strong interaction between Lp(a) and resting platelets, there are no clinical studies on the relationship between Lp(a) and platelet adhesion and aggregation. We measured plasma Lp(a) concentration and platelet function in 103 normal volunteers. Small aggregations of platelets that formed spontaneously (SAG) were measured using laser light scattering. Platelet aggregation was measured by Borns method using epinephrine or ADP as an aggregate. There was no significant difference between HLP (subjects with LP(a)>12mg/dl) and LLP (Lp(a)<12mg/dl) by age, mean blood pressure, body mas index, blood glucose, plasma total cholesterol, triglyceride, high density lipoprotein cholesterol concentrations, prothrombin time, activated partial thromboplastin time, fibrinogen or platelet counts. SAG was significantly higher in HLP than in LLP (p=0.0091). There was no significant difference between HLP and LLP in platelet aggregation when either epinephrine or ADP was used as an aggregate. Log (Lp(a)) correlated with log (SAG) positively (r=0.3116, p=0.001). SAG was inhibited by monoclonal anti glycoprotein IIb/IIIa complex anti body. We concluded that platelet glycoprotein and adhesion may contribute to the relationship between Lp(a) and atherosclerosis.
AbstractList Increased plasma level of lipoprotein (a) (Lp(a)) is associated with atherosclerosis and vascular disease. Though it is well known that there is a strong interaction between Lp(a) and resting platelets, there are no clinical studies on the relationship between Lp(a) and platelet adhesion and aggregation. We measured plasma Lp(a) concentration and platelet function in 103 normal volunteers. Small aggregations of platelets that formed spontaneously (SAG) were measured using laser light scattering. Platelet aggregation was measured by Borns method using epinephrine or ADP as an aggregate. There was no significant difference between HLP (subjects with LP(a)>12mg/dl) and LLP (Lp(a)<12mg/dl) by age, mean blood pressure, body mas index, blood glucose, plasma total cholesterol, triglyceride, high density lipoprotein cholesterol concentrations, prothrombin time, activated partial thromboplastin time, fibrinogen or platelet counts. SAG was significantly higher in HLP than in LLP (p=0.0091). There was no significant difference between HLP and LLP in platelet aggregation when either epinephrine or ADP was used as an aggregate. Log (Lp(a)) correlated with log (SAG) positively (r=0.3116, p=0.001). SAG was inhibited by monoclonal anti glycoprotein IIb/IIIa complex anti body. We concluded that platelet glycoprotein and adhesion may contribute to the relationship between Lp(a) and atherosclerosis.
Author 後藤, 俊哉
玉地, 寛光
川田, 勉
椎名, 豊
安藤, 泰彦
布施川, 雄一
半田, 俊之介
多田, 博巳
瀧川, 修
小熊, 利明
Author_FL HANDA Shunnosuke
KAWADA Tsutomu
GOTO Shunya
TAKIGAWA Osamu
TAMACHI Hiromitsu
ANDO Yasuhiko
SHINA Yutaka
OGUMA Toshiaki
FUSEGAWA Yuichi
TADA Hiromi
Author_FL_xml – sequence: 1
  fullname: FUSEGAWA Yuichi
– sequence: 2
  fullname: TADA Hiromi
– sequence: 3
  fullname: TAKIGAWA Osamu
– sequence: 4
  fullname: OGUMA Toshiaki
– sequence: 5
  fullname: KAWADA Tsutomu
– sequence: 6
  fullname: GOTO Shunya
– sequence: 7
  fullname: SHINA Yutaka
– sequence: 8
  fullname: TAMACHI Hiromitsu
– sequence: 9
  fullname: ANDO Yasuhiko
– sequence: 10
  fullname: HANDA Shunnosuke
Author_xml – sequence: 1
  fullname: 瀧川, 修
  organization: 東海大学医学部循環器内科
– sequence: 1
  fullname: 小熊, 利明
  organization: 東海大学医学部循環器内科
– sequence: 1
  fullname: 布施川, 雄一
  organization: 東海大学医学部循環器内科
– sequence: 1
  fullname: 安藤, 泰彦
  organization: 東海大学医学部臨床病理
– sequence: 1
  fullname: 半田, 俊之介
  organization: 東海大学医学部循環器内科
– sequence: 1
  fullname: 多田, 博巳
  organization: 東海大学医学部循環器内科
– sequence: 1
  fullname: 玉地, 寛光
  organization: 東海大学医学部循環器内科
– sequence: 1
  fullname: 川田, 勉
  organization: 東海大学医学部臨床病理
– sequence: 1
  fullname: 椎名, 豊
  organization: 東海大学医学部循環器内科
– sequence: 1
  fullname: 後藤, 俊哉
  organization: 東海大学医学部循環器内科
BackLink https://cir.nii.ac.jp/crid/1571980074309204224$$DView record in CiNii
BookMark eNo9kL1KA0EUhQeJYIx5ADsLCwU3ztyZ2ZkpJcQfCNhoPUz2RyfETdjdxi6roGJjq0gQa0HU2pCHWWKSt3AlwebcA_fjFN8qKkXdKEBoneAa55zstk1KlKA1YDUCWgJfQmUgkjsSJCuhMqbSdcCVsIKqSWJbGGMlCgDKqN60vW4v7qaBjbbMdp69T1_744-Hn8FofDuYPd9Mr4c7G5Ovx8mgX9Q8e8uz-_zqLs--8-xpPPycvYzW0HJoOklQXdwKOt1vnNQPnebxwVF9r-m0gTDmAPUF8FB4gquWp3wqlSGh73IBvjCKSsloYFxJiQAThNz1le9hYBykH3JjaAVtzncja7Vn_5JwQZTEWDCKFWAGwAqsMcfaSWrOAt2L7YWJL7WJU-t1Ar2wpYHpwtY8C2f_f-_cxAVEfwEwjHXg
ContentType Journal Article
Copyright 一般社団法人 日本動脈硬化学会
Copyright_xml – notice: 一般社団法人 日本動脈硬化学会
DBID RYH
DOI 10.5551/jat1973.24.12_825
DatabaseName CiNii Complete
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Relationship between Lipoprtein(a)and Platelet Adhesion and Aggregation
DocumentTitle_FL Relationship between Lipoprtein(a)and Platelet Adhesion and Aggregation
EISSN 2185-8284
EndPage 829
ExternalDocumentID 10005547455
article_jat1973_24_12_24_12_825_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
KQ8
RJT
RYH
ID FETCH-LOGICAL-j2144-23d725f7c759bc9d389a1fd6572d7a938843ea683172aef56d9dc024528df5aa3
ISSN 0386-2682
IngestDate Fri Jun 27 00:19:46 EDT 2025
Wed Sep 03 06:25:26 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 12
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2144-23d725f7c759bc9d389a1fd6572d7a938843ea683172aef56d9dc024528df5aa3
OpenAccessLink https://www.jstage.jst.go.jp/article/jat1973/24/12/24_12_825/_article/-char/ja
PageCount 5
ParticipantIDs nii_cinii_1571980074309204224
jstage_primary_article_jat1973_24_12_24_12_825_article_char_ja
PublicationCentury 1900
PublicationDate 1997
PublicationDateYYYYMMDD 1997-01-01
PublicationDate_xml – year: 1997
  text: 1997
PublicationDecade 1990
PublicationTitle 動脈硬化
PublicationTitleAlternate 動脈硬化
PublicationTitle_FL The Journal of Japan Atherosclerosis Society
PublicationYear 1997
Publisher 一般社団法人 日本動脈硬化学会
Japan Atherosclerosis Society
Publisher_xml – name: 一般社団法人 日本動脈硬化学会
– name: Japan Atherosclerosis Society
References 3) Eaton DL, Fless GM, and Kohr WJ: Partial amino acid sequence of apolipoprotein (a) shows that it is homologous to plasminogen. Proc Natl Acad Sci USA, 84: 3224-3228, 1987
4) Terres W, Krewitt M, and Hamm CW: Effects of lipoprotein (a) on in vitro lysis of whole blood thrombi from healthy volunteers. Thromb Res, 69: 479-487, 1993
12) Yamamoto T, Egawa Y, Shirasawa Y, Ozaki Y, Sato K, Yatomi Y, and Kume H: A laser light scattering in situ system for counting aggregates in blood platelet aggregation. Meas Sci Technol, 6: 174-180, 1995
11) Ozaki Y, Satoh K, Yatomi Y, Yamamoto T, Shirasawa Y, and Kume S: Detection of platelet aggregates with a particle counting method using light scatting. Anal Biochem, 218: 284-294, 1994
14) Szczeklik A, Radwan A, Kubicka M, Sacha J, Swadzba A, Undas J, and Jodlowski J: Plasma fibrinolysis activity in healthy subjects with high and low lipoprotein (a) concentrations. Thromb Res, 66: 391-395, 1992
16) Tsakiris DA, Riesen WF, and Marbet GA: Lipoprotein (a) and hemostasis activation markers in angina pectoris. Dtsch Med Wochenschr, 120(33): 1109-1113, 1995
17) Opper C, Clement C, Schwarz H, Krappe J, Steinmetz A, Schneider J, and Wesemann W: Increased number of high sensitive plateles in hypercholesterolemia, cardiovascular diseases, and after incubation with cholesterol. Atherosclerosis, 113: 211-217, 1995
1) Kostner GM, Avogaro P, and Cazzolato G: Lipoprotein Lp (a) and risk for myocardial infarction. Atherosclerosis, 38: 51-61, 1981
6) Heinrich J, Sandkamp M, Kokott R, Schulte H, and Assmann G: Relationship of lipoprotein (a) to variables of coagulation and fibrinolysis in a healthy population. Clin Chem, 37(11): 1950-1954, 1991
9) Ross R: The pathogenesis of atherosclerosis-an update. N Engle J Med, 314: 488-496, 1986
13) Annika R, Lars W, Elsa E, and Bo R: Lipoprotein (a) and coronary heart disease: A prospective casecontrol study in a general population sample of middle aged men. BMJ, 301(1, 12): 1248-1251, 1990
10) Born GVR: Aggregation of blood platelets by adenosine disphosphate and its revarsal. Nature, 194: 927-928, 1962
2) Murai A, Miyahara T, Fujimoto N, Matsuda M, and Kaneyama M: Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Athrosclerosis, 59: 199-204, 1986
8) Malle E, Ibovnik A, Steinmetz A, Kostner GM, and Sattler W: Identification of glycoprotein IIb as the lipoprotein (a) binding protein on platelets. Arteriosclerosis and Thrombosis, 14 (3): 345-352, 1994
15) Blencowe C, Hermetter A, Kostner GM, and Deigner HP: Enhanced association of platelet activating factor acetylhydrolase with lipoprotein (a) in comparison with low density lipoprotein. J Biol Chem, 270(52): 31151-31157, 1995
18) Breddin HK, Krzywanak HJ, Althoff P, Kirchmaier CM, Rosak C, Schepping M, Weichert W, Ziemen M, Schoffling K, and Uberta K: Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics. Results of the PARD study. Int Angiol, 5 (3): 181-195, 1986
5) Liu J, Harpel PC, Pannell R, and Gurewich V: Lipoprotein (a): A kinetic study of its influence on fibrin-dependent plasminogen activation by prourokinase or tissue plasminogen activator. Biochemistry, 32: 9694-9700, 1993
7) Plow EF, D' Souza SE, and Ginsberg NH: Liganding binding to GPIIb-III: a status report. Semin Thromb Haemost, 18: 324-332, 1992
References_xml – reference: 1) Kostner GM, Avogaro P, and Cazzolato G: Lipoprotein Lp (a) and risk for myocardial infarction. Atherosclerosis, 38: 51-61, 1981
– reference: 16) Tsakiris DA, Riesen WF, and Marbet GA: Lipoprotein (a) and hemostasis activation markers in angina pectoris. Dtsch Med Wochenschr, 120(33): 1109-1113, 1995
– reference: 6) Heinrich J, Sandkamp M, Kokott R, Schulte H, and Assmann G: Relationship of lipoprotein (a) to variables of coagulation and fibrinolysis in a healthy population. Clin Chem, 37(11): 1950-1954, 1991
– reference: 2) Murai A, Miyahara T, Fujimoto N, Matsuda M, and Kaneyama M: Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Athrosclerosis, 59: 199-204, 1986
– reference: 18) Breddin HK, Krzywanak HJ, Althoff P, Kirchmaier CM, Rosak C, Schepping M, Weichert W, Ziemen M, Schoffling K, and Uberta K: Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics. Results of the PARD study. Int Angiol, 5 (3): 181-195, 1986
– reference: 5) Liu J, Harpel PC, Pannell R, and Gurewich V: Lipoprotein (a): A kinetic study of its influence on fibrin-dependent plasminogen activation by prourokinase or tissue plasminogen activator. Biochemistry, 32: 9694-9700, 1993
– reference: 4) Terres W, Krewitt M, and Hamm CW: Effects of lipoprotein (a) on in vitro lysis of whole blood thrombi from healthy volunteers. Thromb Res, 69: 479-487, 1993
– reference: 9) Ross R: The pathogenesis of atherosclerosis-an update. N Engle J Med, 314: 488-496, 1986
– reference: 8) Malle E, Ibovnik A, Steinmetz A, Kostner GM, and Sattler W: Identification of glycoprotein IIb as the lipoprotein (a) binding protein on platelets. Arteriosclerosis and Thrombosis, 14 (3): 345-352, 1994
– reference: 17) Opper C, Clement C, Schwarz H, Krappe J, Steinmetz A, Schneider J, and Wesemann W: Increased number of high sensitive plateles in hypercholesterolemia, cardiovascular diseases, and after incubation with cholesterol. Atherosclerosis, 113: 211-217, 1995
– reference: 7) Plow EF, D' Souza SE, and Ginsberg NH: Liganding binding to GPIIb-III: a status report. Semin Thromb Haemost, 18: 324-332, 1992
– reference: 15) Blencowe C, Hermetter A, Kostner GM, and Deigner HP: Enhanced association of platelet activating factor acetylhydrolase with lipoprotein (a) in comparison with low density lipoprotein. J Biol Chem, 270(52): 31151-31157, 1995
– reference: 13) Annika R, Lars W, Elsa E, and Bo R: Lipoprotein (a) and coronary heart disease: A prospective casecontrol study in a general population sample of middle aged men. BMJ, 301(1, 12): 1248-1251, 1990
– reference: 14) Szczeklik A, Radwan A, Kubicka M, Sacha J, Swadzba A, Undas J, and Jodlowski J: Plasma fibrinolysis activity in healthy subjects with high and low lipoprotein (a) concentrations. Thromb Res, 66: 391-395, 1992
– reference: 12) Yamamoto T, Egawa Y, Shirasawa Y, Ozaki Y, Sato K, Yatomi Y, and Kume H: A laser light scattering in situ system for counting aggregates in blood platelet aggregation. Meas Sci Technol, 6: 174-180, 1995
– reference: 3) Eaton DL, Fless GM, and Kohr WJ: Partial amino acid sequence of apolipoprotein (a) shows that it is homologous to plasminogen. Proc Natl Acad Sci USA, 84: 3224-3228, 1987
– reference: 11) Ozaki Y, Satoh K, Yatomi Y, Yamamoto T, Shirasawa Y, and Kume S: Detection of platelet aggregates with a particle counting method using light scatting. Anal Biochem, 218: 284-294, 1994
– reference: 10) Born GVR: Aggregation of blood platelets by adenosine disphosphate and its revarsal. Nature, 194: 927-928, 1962
SSID ssib000972182
ssj0003239275
ssib002821934
Score 1.4435827
Snippet Increased plasma level of lipoprotein (a) (Lp(a)) is associated with atherosclerosis and vascular disease. Though it is well known that there is a strong...
SourceID nii
jstage
SourceType Publisher
StartPage 825
SubjectTerms Glycoprotein IIb
IIIa complex
Platelet small aggregation formed spontaneously Lipoprotein(a)
Title Lipoprotein(a)の血小板凝集能, 粘着能におよぼす影響
URI https://www.jstage.jst.go.jp/article/jat1973/24/12/24_12_825/_article/-char/ja
https://cir.nii.ac.jp/crid/1571980074309204224
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 動脈硬化, 1997/09/30, Vol.24(12), pp.825-829
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1Na9RANLT14kUUFatWenBAwV0385GZuQjJNktREYQWegv5hO1hW2R78dRVUPHiVZEingVRz5b-Bf_DUtv-C997yaZZFbQKYfYx8-Z9TSZ5b3bmxXGu51ponac5TCRPQIAiVCvmRd6CeadzLyl0nNAu3wfe8qq8u6bWZma_NXYtbQ2Tdvr4t-dK_mVUoQ7GFU_JnmBka6JQATCML5QwwlD-1Rjf729uUKIFjO4NuIGWhQJ8Q-aHLDTMd3EfQ6hY0GGmx0KP2SUW9LDGaIRDy2zAjIfIRrBgCQ3OQs0CzqxBAJCQxKS5oh5UgPEJ4MyYqiboVoC1xBj4ucSmB4ybjjAJETCriLgkChol9rvU1GW2XjPEFpDC10SShCI5JSrjh8dotaYalQLpCE0hcd-S_sBrGp80wxaP9JuiX1pHEiPA6zQ7goWNRdktSC1LfCAhUIJScd87XlHBfTb13V_TI9UNaUxEghC7Ak9fVMTQPFDvw0X0kZkioDsx1B9sSLKiMEQIavzGo18Yr8W98rNM7ZzqwBdTeOhfNt9d5fnzyRzljTeRKc-TT5yaclnp5_elAn-ZvtMwdK0WbS7bLo_qnlNpyKubPKpwIy4jwC1L6BFN2vGwICDNOqe41i5usr33sOHwY7IoM_U_PkQQsl4VFRz8dcqOXZug3IqAkt7-RU5wG9chiMLsGLODfr_hGa6cdc5UId2iX4p2zplZj8873cbcvBHfHI8-Hr7f3v_06vvO3v7znaO3zw6f7t5aPPjy-mBnG8Dx6MN49HL85MV49HU8erO_-_no3d4FZ7UXrnSXW9UHS1rrmHmwxUWmuSp0qpVNUptBMBC7ReYpzTMdW2GMFHnsGfDZeZwXystsltLeB5MVKo7FRWdusDHILzmLlJmxUGkilYarSOApGuOvNB0bm2zeuVNqHm2WWWmiEw7QvLMAFovSPpau0q41FE50LMe0gPLy_zK44pwuUz3jcuVVZ274aCtfAAd-mFyje-IHyQu7Yw
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lipoprotein%28a%29%E3%81%AE%E8%A1%80%E5%B0%8F%E6%9D%BF%E5%87%9D%E9%9B%86%E8%83%BD%2C+%E7%B2%98%E7%9D%80%E8%83%BD%E3%81%AB%E3%81%8A%E3%82%88%E3%81%BC%E3%81%99%E5%BD%B1%E9%9F%BF&rft.jtitle=%E5%8B%95%E8%84%88%E7%A1%AC%E5%8C%96&rft.au=%E7%80%A7%E5%B7%9D%2C+%E4%BF%AE&rft.au=%E5%B0%8F%E7%86%8A%2C+%E5%88%A9%E6%98%8E&rft.au=%E5%B8%83%E6%96%BD%E5%B7%9D%2C+%E9%9B%84%E4%B8%80&rft.au=%E5%AE%89%E8%97%A4%2C+%E6%B3%B0%E5%BD%A6&rft.date=1997&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%8B%95%E8%84%88%E7%A1%AC%E5%8C%96%E5%AD%A6%E4%BC%9A&rft.issn=0386-2682&rft.eissn=2185-8284&rft.volume=24&rft.issue=12&rft.spage=825&rft.epage=829&rft_id=info:doi/10.5551%2Fjat1973.24.12_825&rft.externalDocID=article_jat1973_24_12_24_12_825_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0386-2682&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0386-2682&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0386-2682&client=summon